ClinVar Miner

Submissions for variant NM_000057.4(BLM):c.178T>A (p.Leu60Ile)

gnomAD frequency: 0.00007  dbSNP: rs138542210
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 11
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Laboratory Services, Illumina RCV000330317 SCV000394408 likely benign Bloom syndrome 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease.
Labcorp Genetics (formerly Invitae), Labcorp RCV000330317 SCV000555845 benign Bloom syndrome 2025-01-29 criteria provided, single submitter clinical testing
Ambry Genetics RCV000562376 SCV000672886 likely benign Hereditary cancer-predisposing syndrome 2020-12-17 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Cancer Genomics Group, Japanese Foundation For Cancer Research RCV001030679 SCV001193507 uncertain significance Hereditary breast ovarian cancer syndrome 2019-05-01 criteria provided, single submitter research
Quest Diagnostics Nichols Institute San Juan Capistrano RCV001800407 SCV002046932 benign not provided 2021-04-22 criteria provided, single submitter clinical testing
Genetic Services Laboratory, University of Chicago RCV000120241 SCV002068919 uncertain significance not specified 2019-09-09 criteria provided, single submitter clinical testing
Sema4, Sema4 RCV000562376 SCV002533647 likely benign Hereditary cancer-predisposing syndrome 2022-01-19 criteria provided, single submitter curation
ITMI RCV000120241 SCV000084389 not provided not specified 2013-09-19 no assertion provided reference population
Department of Pediatrics, Samsung Medical Center, Samsung Medical Center RCV001252853 SCV001163996 uncertain significance Microcephaly no assertion criteria provided research
Natera, Inc. RCV000330317 SCV001456975 benign Bloom syndrome 2019-08-06 no assertion criteria provided clinical testing
PreventionGenetics, part of Exact Sciences RCV003915190 SCV004734661 likely benign BLM-related disorder 2020-10-13 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.